Werbung

Zu diesem Instrument liegen derzeit keine aktuellen Daten vor.

Anlageziel

The investment objective of the Sub-Fund is to achieve long-term capital growth and to create a positive societal impact through investment in an actively managed portfolio of equity securities of companies engaged in the health care sector. The Sub-Fund will invest, under normal market conditions, primarily in Equity and Equity-Related Securities of companies engaged in the health care sector, which are listed or traded on a Recognised Exchange and which companies may be selected from the Index. The Sub-Fund will consist of health care companies, which are companies classified in the health care category as per the Global Industry Classification Standard (GICS®) and / or those companies that otherwise, in the opinion of the Investment Manager, promote the philosophy of healthy lives and well-being for all and are innovative and capable of sustainable business development (“Health Care Companies”).

Stammdaten

Name Nomura Funds Ireland plc - American Century Advanced Medical Impact Equity Fund A EUR Acc Fonds
ISIN IE00BMH6QG20
WKN A2QLWG
Fondsgesellschaft Nomura Asset Management U.K. Limited
Benchmark MSCI World/Health Care
Ausschüttungsart Thesaurierend
Manager Michael X Li, Henry He
Domizil Ireland
Fondskategorie Aktien
Auflagedatum 25.01.2021
Geschäftsjahr 31.12.
VL-fähig? Nein
Depotbank Brown Brothers Harriman Trustee Services (Ireland) Limited
Zahlstelle Nomura Bank (Schweiz) AG
Riester Fonds Nein

mehr

Basisdaten

Auflagedatum 25.01.2021
Depotbank Brown Brothers Harriman Trustee Services (Ireland) Limited
Zahlstelle Nomura Bank (Schweiz) AG
Domizil Ireland
Geschäftsjahr 31.12.

Aktuelle Daten

Morningstar Rating
Aktueller Rücknahmepreis 103,21
Anzahl Fonds der Kategorie 789
Volumen der Tranche 4.123,00 EUR
Fondsvolumen 4,26 Mio. EUR
Total Expense Ratio (TER) 1,95

Gebühren

Laufende Kosten 1,95%
Total Expense Ratio (Verwaltungsgebühren & sonst. Kosten) 1,95%
Transaktionskosten -
Depotbankgebühr -
Managementgebühr 1,80%
Rücknahmegebühr -
Ausgabeaufschlag 5,00%

Performancedaten

Veränderung Vortag -0,20
WE seit Jahresbeginn